It is a protein that serves as an indicator of cell proliferation, used to predict malignancy and prognosis in tumors like breast cancer.

What are the features of the developed AI?

It detects cell nuclei from digital pathology images, automatically classifies Ki-67 positive/negative cells, and calculates the positive rate with high accuracy.

What is the future outlook?

The company plans to develop AI capable of quantitatively evaluating other nuclear proteins like P53 and cell membrane proteins.

AI News NQ Analysis

Medmain Develops AI to Automatically Measure Ki-67 Positive Cell Rate in Immunohistochemical Specimens - Paper Published in Diagnostics -

NQ Score 50/100

AI Summary (NQ-processed)

Medmain Inc. has successfully developed an AI model that automatically detects and measures the Ki-67 positive cell rate in immunohistochemical digital specimens. The AI demonstrated high accuracy, assisting pathologists in cancer diagnosis, and the research was published in the academic journal 'Diagnostics'.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is Ki-67?: A: It is a protein that serves as an indicator of cell proliferation, used to predict malignancy and prognosis in tumors like breast cancer.
Q: What are the features of the developed AI?: A: It detects cell nuclei from digital pathology images, automatically classifies Ki-67 positive/negative cells, and calculates the positive rate with high accuracy.
Q: What is the future outlook?: A: The company plans to develop AI capable of quantitatively evaluating other nuclear proteins like P53 and cell membrane proteins.